Cervical ectropion is a common gynecological infection that can reduce fertility and increase the risk of cervical cancer. Therefore, timely detection and treatment of the disease is important in minimizing the negative effects of the disease on women's reproductive health.

Cervical ectropion is common in women of childbearing age. The disease is not life-threatening but can negatively affect the patient's daily quality of life, causing itching, discomfort, odor, etc. If not treated promptly, cervical ectropion can lead to infertility.

If not treated early and properly, cervical ectropion can cause many serious consequences such as: abnormal fetal development, miscarriage in the first 3 months, premature birth or difficulty in labor.

Cervical ectropion occurs when cells from inside the cervical canal migrate to the outer surface, forming an exposed area and becoming inflamed. Although this is a completely benign lesion, treatment of cervical ectropion must be aggressive from the beginning to avoid the risk of malignancy later. In particular, antibiotics play an important role if the agent causing inflammation is a microorganism.

Cervical ectropion is a benign condition in which the cervix is damaged by glandular cells that grow and invade the outside of the cervix. The disease has symptoms quite similar to other gynecological infections such as discharge with odor, increased vaginal discharge, etc., which can easily cause infection. Cervical ectropion is divided into 3 levels from severe to mild.

Cervical ectropion can cause inflammation and blockage of the fallopian tubes, endometritis, and can easily lead to infertility. Currently, there are many medical methods to treat the disease depending on the level of ectropion damage at level 1, 2, or 3.